01253nam 2200265la 450 991048182070332120221108080946.0(UK-CbPIL)2090341649(CKB)5500000000085664(EXLCZ)99550000000008566420210618d1597 uy |laturcn||||a|bb|Aur. Theodosii Macrobii ... Opera Ioh. Isacius Pontanus recensuit: & Saturnaliorum libros MS. ope auxit, ordinavit, et castigationes sive notas adiecit ad amplissimum virum Arnoldum Witfeldium regni Daniæ cancellarium[electronic resource]Leiden Franciscus Raphelengius1597Online resource ([16], 697, [55] s.)Reproduction of original in Det Kongelige Bibliotek / The Royal Library (Copenhagen).Macrobius Ambrosius Theodosius440771Meurs Johannes van1579-1639.328473Uk-CbPILUk-CbPILBOOK9910481820703321Aur. Theodosii Macrobii ... Opera Ioh. Isacius Pontanus recensuit: & Saturnaliorum libros MS. ope auxit, ordinavit, et castigationes sive notas adiecit ad amplissimum virum Arnoldum Witfeldium regni Daniæ cancellarium1953425UNINA02724nam 2200349 450 991068815970332120230702172755.0(CKB)5580000000514488(NjHacI)995580000000514488(EXLCZ)99558000000051448820230702d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierFrom Pathophysiology to Treatment of Huntington's Disease /edited by Natalia SzejkoLondon :IntechOpen,2022.1 online resource (170 pages)1-80355-428-2 1. Neuropathology in Huntington's Disease: A Balancing Act between Neurodegeneration and Aggregates -- 2. Neuropathology of Huntington's Disease -- 3. Exploring Biomarkers for Huntington's Disease -- 4. Neuroimaging Biomarkers for Huntington's Disease -- 5. Endocannabinoid System as a New Therapeutic Avenue for the Treatment of Huntington's Disease -- 6. Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment -- 7. Nrf2 as a Potential Therapeutic Target for Treatment of Huntington's Disease.Huntington's Disease (HD) is a progressive neurodegenerative disease leading to a variety of neurological and psychiatric symptoms such as chorea, parkinsonism, oculomotor symptoms, cognitive decline, depression, suicidal ideation, and psychosis. Currently, only symptomatic treatment is available. In recent years, there has been a growing number of publications regarding pathophysiology, disease biomarkers, and possible avenues for causal therapy of HD. This book presents an overview of the most important research updates in the pathophysiology and treatment of HD, with particular reference to advances in HD neuropathology, neuroimaging, and biomarkers of HD. We also summarize possible new therapeutic targets, including cannabis-based medicine, cellular, and cell-free therapeutics. Importantly, researchers from different regions of the world have contributed to this volume as we wanted to create a balanced, inclusive, and interdisciplinary review of the topics. We hope that with this book readers will be offered a compact summary of up-to-date trends in HD research which, ultimately, will enable better diagnosis and treatment for HD patients.Huntington's diseasePathophysiologyHuntington's diseasePathophysiology.616.851Szejko NataliaNjHacINjHaclBOOK9910688159703321From Pathophysiology to Treatment of Huntington's Disease2994979UNINA